O	0	8	Distinct	Distinct	JJ	B-NP
O	9	13	role	role	NN	I-NP
O	14	16	of	of	IN	B-PP
O	17	25	PLCbeta3	PLCbeta3	NN	B-NP
O	26	28	in	in	IN	B-PP
O	29	33	VEGF	VEGF	NN	B-NP
O	33	34	-	-	HYPH	O
O	34	42	mediated	mediate	VBN	B-VP
O	43	54	directional	directional	JJ	B-NP
O	55	64	migration	migration	NN	I-NP
O	65	68	and	and	CC	O
B-Multi-tissue_structure	69	77	vascular	vascular	JJ	B-NP
O	78	87	sprouting	sprouting	NN	I-NP
O	87	88	.	.	.	O

B-Cell	89	100	Endothelial	Endothelial	JJ	B-NP
I-Cell	101	105	cell	cell	NN	I-NP
O	106	119	proliferation	proliferation	NN	I-NP
O	120	123	and	and	CC	O
O	124	133	migration	migration	NN	B-NP
O	134	136	is	be	VBZ	B-VP
O	137	146	essential	essential	JJ	B-ADJP
O	147	149	to	to	TO	B-PP
O	150	162	angiogenesis	angiogenesis	NN	B-NP
O	162	163	.	.	.	O

O	164	173	Typically	Typically	RB	B-ADVP
O	173	174	,	,	,	O
O	175	188	proliferation	proliferation	NN	B-NP
O	189	192	and	and	CC	I-NP
O	193	203	chemotaxis	chemotaxis	NN	I-NP
O	204	206	of	of	IN	B-PP
B-Cell	207	218	endothelial	endothelial	JJ	B-NP
I-Cell	219	224	cells	cell	NNS	I-NP
O	225	227	is	be	VBZ	B-VP
O	228	234	driven	drive	VBN	I-VP
O	235	237	by	by	IN	B-PP
O	238	244	growth	growth	NN	B-NP
O	245	252	factors	factor	NNS	I-NP
O	253	257	such	such	JJ	B-PP
O	258	260	as	as	IN	I-PP
O	261	269	vascular	vascular	JJ	B-NP
O	270	281	endothelial	endothelial	JJ	I-NP
O	282	288	growth	growth	NN	I-NP
O	289	295	factor	factor	NN	I-NP
O	296	297	(	(	(	O
O	297	301	VEGF	VEGF	NN	B-NP
O	301	302	)	)	)	O
O	303	306	and	and	CC	O
O	307	312	basic	basic	JJ	B-NP
O	313	323	fibroblast	fibroblast	NN	I-NP
O	324	330	growth	growth	NN	I-NP
O	331	337	factor	factor	NN	I-NP
O	338	339	(	(	(	O
O	339	343	bFGF	bFGF	NN	B-NP
O	343	344	)	)	)	O
O	344	345	.	.	.	O

O	346	350	VEGF	VEGF	NN	B-NP
O	351	360	activates	activate	VBZ	B-VP
O	361	375	phospholipases	phospholipas	NNS	B-NP
O	376	377	(	(	(	O
O	377	381	PLCs	PLC	NNS	B-NP
O	381	382	)	)	)	O
O	383	384	-	-	HYPH	O
O	385	397	specifically	specifically	RB	B-NP
O	398	407	PLCgamma1	PLCgamma1	NN	I-NP
O	408	409	-	-	HYPH	O
O	410	414	that	that	WDT	B-NP
O	415	418	are	be	VBP	B-VP
O	419	428	important	important	JJ	B-ADJP
O	429	432	for	for	IN	B-PP
O	433	446	tubulogenesis	tubulogenesis	NN	B-NP
O	446	447	,	,	,	O
O	448	463	differentiation	differentiation	NN	B-NP
O	464	467	and	and	CC	O
O	468	471	DNA	DNA	NN	B-NP
O	472	481	synthesis	synthesis	NN	I-NP
O	481	482	.	.	.	O

O	483	490	However	However	RB	B-ADVP
O	490	491	,	,	,	O
O	492	494	we	we	PRP	B-NP
O	495	499	show	show	VBP	B-VP
O	500	504	here	here	RB	B-ADVP
O	505	509	that	that	IN	B-SBAR
O	510	514	VEGF	VEGF	NN	B-NP
O	514	515	,	,	,	O
O	516	528	specifically	specifically	RB	B-ADVP
O	529	536	through	through	IN	B-PP
O	537	543	VEGFR2	VEGFR2	NN	B-NP
O	543	544	,	,	,	O
O	545	552	induces	induce	VBZ	B-VP
O	553	568	phosphorylation	phosphorylation	NN	B-NP
O	569	571	of	of	IN	B-PP
O	572	575	two	two	CD	B-NP
O	576	582	serine	serine	NN	I-NP
O	583	591	residues	residue	NNS	I-NP
O	592	594	on	on	IN	B-PP
O	595	603	PLCbeta3	PLCbeta3	NN	B-NP
O	603	604	,	,	,	O
O	605	608	and	and	CC	O
O	609	613	this	this	DT	B-NP
O	614	617	was	be	VBD	B-VP
O	618	627	confirmed	confirm	VBN	I-VP
O	628	630	in	in	IN	B-PP
O	631	633	an	an	DT	B-NP
O	634	636	ex	ex	FW	I-NP
O	637	641	vivo	vivo	FW	I-NP
B-Developing_anatomical_structure	642	650	embryoid	embryoid	JJ	I-NP
I-Developing_anatomical_structure	651	655	body	body	NN	I-NP
O	656	661	model	model	NN	I-NP
O	661	662	.	.	.	O

O	663	672	Knockdown	Knockdown	NN	B-NP
O	673	675	of	of	IN	B-PP
O	676	684	PLCbeta3	PLCbeta3	NN	B-NP
O	685	687	in	in	IN	B-PP
B-Cell	688	693	HUVEC	HUVEC	NN	B-NP
I-Cell	694	699	cells	cell	NNS	I-NP
O	700	707	affects	affect	VBZ	B-VP
O	708	711	IP3	IP3	NN	B-NP
O	712	722	production	production	NN	I-NP
O	722	723	,	,	,	O
O	724	729	actin	actin	NN	B-NP
O	730	744	reorganization	reorganization	NN	I-NP
O	744	745	,	,	,	O
O	746	755	migration	migration	NN	B-NP
O	756	759	and	and	CC	I-NP
O	760	773	proliferation	proliferation	NN	I-NP
O	773	774	;	;	:	O
O	775	782	whereas	whereas	IN	B-PP
O	783	792	migration	migration	NN	B-NP
O	793	795	is	be	VBZ	B-VP
O	796	805	inhibited	inhibit	VBN	I-VP
O	805	806	,	,	,	O
O	807	820	proliferation	proliferation	NN	B-NP
O	821	823	is	be	VBZ	B-VP
O	824	832	enhanced	enhance	VBN	I-VP
O	832	833	.	.	.	O

O	834	837	Our	Our	PRP$	B-NP
O	838	842	data	datum	NNS	I-NP
O	843	850	suggest	suggest	VBP	B-VP
O	851	855	that	that	IN	B-SBAR
O	856	864	enhanced	enhance	VBN	B-NP
O	865	878	proliferation	proliferation	NN	I-NP
O	879	881	is	be	VBZ	B-VP
O	882	894	precipitated	precipitate	VBN	I-VP
O	895	897	by	by	IN	B-PP
O	898	900	an	an	DT	B-NP
O	901	912	accelerated	accelerate	VBN	I-NP
B-Cell	913	917	cell	cell	NN	I-NP
O	918	923	cycle	cycle	NN	I-NP
O	923	924	,	,	,	O
O	925	928	and	and	CC	O
O	929	938	decreased	decrease	VBD	B-VP
O	939	948	migration	migration	NN	B-NP
O	949	951	by	by	IN	B-PP
O	952	954	an	an	DT	B-NP
O	955	964	inability	inability	NN	I-NP
O	965	967	to	to	TO	B-VP
O	968	976	activate	activate	VB	I-VP
O	977	982	CDC42	CDC42	NN	B-NP
O	982	983	.	.	.	O

O	984	989	Given	Give	VBN	B-VP
O	990	994	that	that	IN	B-SBAR
O	995	1003	PLCbeta3	PLCbeta3	NN	B-NP
O	1004	1006	is	be	VBZ	B-VP
O	1007	1016	typically	typically	RB	I-VP
O	1017	1022	known	know	VBN	I-VP
O	1023	1025	as	as	IN	B-PP
O	1026	1028	an	an	DT	B-NP
O	1029	1037	effector	effector	NN	I-NP
O	1038	1040	of	of	IN	B-PP
O	1041	1055	heterotrimeric	heterotrimeric	JJ	B-NP
O	1056	1057	G	G	NN	I-NP
O	1057	1058	-	-	HYPH	I-NP
O	1058	1066	proteins	protein	NNS	I-NP
O	1066	1067	,	,	,	O
O	1068	1071	our	our	PRP$	B-NP
O	1072	1076	data	datum	NNS	I-NP
O	1077	1088	demonstrate	demonstrate	VBP	B-VP
O	1089	1090	a	a	DT	B-NP
O	1091	1097	unique	unique	JJ	I-NP
O	1098	1107	crosstalk	crosstalk	NN	I-NP
O	1108	1115	between	between	IN	B-PP
O	1116	1119	the	the	DT	B-NP
O	1120	1121	G	G	NN	I-NP
O	1121	1122	-	-	HYPH	B-NP
O	1122	1129	protein	protein	NN	I-NP
O	1130	1133	and	and	CC	I-NP
O	1134	1142	receptor	receptor	NN	I-NP
O	1143	1151	tyrosine	tyrosine	NN	I-NP
O	1152	1158	kinase	kinase	NN	I-NP
O	1159	1160	(	(	(	O
O	1160	1163	RTK	RTK	NN	B-NP
O	1163	1164	)	)	)	O
O	1165	1169	axes	ax	NNS	B-NP
O	1170	1173	and	and	CC	O
O	1174	1180	reveal	reveal	VB	B-VP
O	1181	1182	a	a	DT	B-NP
O	1183	1188	novel	novel	JJ	I-NP
O	1189	1198	molecular	molecular	JJ	I-NP
O	1199	1208	mechanism	mechanism	NN	I-NP
O	1209	1211	of	of	IN	B-PP
O	1212	1216	VEGF	VEGF	NN	B-NP
O	1217	1226	signaling	signaling	NN	I-NP
O	1227	1230	and	and	CC	O
O	1230	1231	,	,	,	O
O	1232	1236	thus	thus	RB	B-ADVP
O	1236	1237	,	,	,	O
O	1238	1250	angiogenesis	angiogenesis	NN	B-NP
O	1250	1251	.	.	.	O

